LAVA Therapeutics N.V. (LVTX) Misses Q3 EPS by 13c
Tweet
Share
E-mailGet Alerts LVTX Hot Sheet
Join SI Premium – FREE
LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.46), $0.13 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- Roblox announces standalone apps, browser play, and creator wallet
- BetterLife Pharma files final prospectus for $100M public offering
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
